Literature DB >> 4939602

Clofibrate and fat embolism: a double-blind trial of the effects of clofibrate on sequelae to injury.

W G Cole.   

Abstract

In a double-blind prospective trial clofibrate was found not to influence significantly the clinical and laboratory indices thought to reflect the state of fat embolism in patients with fractures.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4939602      PMCID： PMC1799022          DOI： 10.1136/bmj.4.5780.148

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  4 in total

1.  THE EFFECTS OF CHLOROPHENOXYISOBUTYRATE WITH AND WITHOUT ANDROSTERONE ON THE SERUM LIPIDS, FAT TOLERANCE, AND URIC ACID.

Authors:  D BERKOWITZ
Journal:  Metabolism       Date:  1965-09       Impact factor: 8.694

2.  Determination of serum glycerides.

Authors:  L A CARLSON
Journal:  Acta Soc Med Ups       Date:  1959

3.  Oxygen electrode calibration.

Authors:  N Rogers; M Laver; M C Pain
Journal:  Med J Aust       Date:  1968-10-05       Impact factor: 7.738

4.  Injury, serum lipids, fat embolism, and clofibrate.

Authors:  M O'Driscoll; F J Powell
Journal:  Br Med J       Date:  1967-10-28
  4 in total
  3 in total

Review 1.  Fat embolism. Report of two cases and review of current concepts.

Authors:  J Ndiyob
Journal:  J Natl Med Assoc       Date:  1975-07       Impact factor: 1.798

2.  Clofibrate and fat embolism.

Authors:  J C McPherson; W S Harms; L T Ellison; R G Ellison
Journal:  Br Med J       Date:  1972-08-19

3.  Preventing fat embolism.

Authors: 
Journal:  Br Med J       Date:  1978-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.